X-Chem, Inc. (X-Chem), the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn, a Montreal-based drug discovery services company and its US-based sister company, AviSyn. The transaction will enable the Company to offer a complete, seamless solution for screening, hit validation and lead optimization on existing and new markets. Leveraging a proprietary DEX platform with libraries containing over 200 billion small molecules, X-Chem discovers new drug leads for biopharma clients.
Read the full article: X-Chem Acquires IntelliSyn and Sister Company, AviSyn, to Extend and Streamline Drug Discovery Service Range //
Source: https://www.businesswire.com/news/home/20210126005069/en/X-Chem-Acquires-IntelliSyn-and-Sister-Company-AviSyn-to-Extend-and-Streamline-Drug-Discovery-Service-Range